SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lathrop, D. A.
Right arrow Articles by Schwartz, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Lathrop, D. A.
Right arrow Articles by Schwartz, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Comparison of the Electromechanical Effects of Vesnarinone and Amrinone in Isolated Dog Purkinje Strands and Ventricular Trabeculae

David A. Lathrop, PhD

Institute of Molecular Pharmacology and Biophysics. University of Cincinnati College of Medicine, Cincinnati, Ohio, Department of Medicinal Physiology. University of Tromso, Tromso, Norway. Department of Physiology, University Medical School of Debrecen, Debrecen, Hungary, and Department of Pharmacology, Albert Szent-György School of Medicine, Szeged, Hungary.

Péter P. Náinási, MD, PhD

Institute of Molecular Pharmacology and Biophysics. University of Cincinnati College of Medicine, Cincinnati, Ohio, Department of Medicinal Physiology. University of Tromso, Tromso, Norway. Department of Physiology, University Medical School of Debrecen, Debrecen, Hungary, and Department of Pharmacology, Albert Szent-György School of Medicine, Szeged, Hungary.

András Varró, MD, PhD

Institute of Molecular Pharmacology and Biophysics. University of Cincinnati College of Medicine, Cincinnati, Ohio, Department of Medicinal Physiology. University of Tromso, Tromso, Norway. Department of Physiology, University Medical School of Debrecen, Debrecen, Hungary, and Department of Pharmacology, Albert Szent-György School of Medicine, Szeged, Hungary.

Arnold Schwartz, PhD

Institute of Molecular Pharmacology and Biophysics. University of Cincinnati College of Medicine, Cincinnati, Ohio, Department of Medicinal Physiology. University of Tromso, Tromso, Norway. Department of Physiology, University Medical School of Debrecen, Debrecen, Hungary, and Department of Pharmacology, Albert Szent-György School of Medicine, Szeged, Hungary.

Background: Conventional microelectrode techniques were used to compare the concentration-dependent effects of vesnarinone (0.1-100 µM) and amrinone (1 µM-1 mm) on action potential duration (APD) and developed force in both isolated dog ventricular trabeculae and Purkinje strands.

Methods and Results: Both drugs increased contractility of trabecular muscle preparations, while, in Purkinje strands, vesnarinone failed to increase developed force during continuous pacing at 2 Hz. Vesnarinone lengthened APD in both preparations; although this effect was more marked in Purkinje strands. Ventricular muscle APD was not affected by amrinone (1 µM to 1 mM), while, in Purkinje strands, amrinone produced a biphasic effect on APD. Low concentrations (1-100 µM) of amrinone shortened Purkinje fiber APD, while only the highest concentration (1 mM) used lengthened APD. In addition, in Purkinje strand preparations the effects of vesnarinone (10 µM) on APD and developed force were proportional to pacing cycle length at frequencies slower than 2 Hz; however, at frequencies faster than 2 Hz vesnarinone decreased developed force while APD was lengthened. In ventricular trabecular muscle preparations, the effects of vesnarinone were not affected by frequency.

Conclusions: These results indicate clear differences between the effects of vesnarinone and amrinone in isolated cardiac preparations. These differences in experimental effects in isolated cardiac preparations may help provide an explanation for the disappointing clinical response of patients in heart failure to amrinone, while vesnarinone has appeared to be beneficial.

Key Words: positive inotropy • phosphodiesterase inhibitors • action potential duration • force development • vesnarinone • amrinone.

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 1, No. 2, 133-140 (1996)
DOI: 10.1177/107424849600100207


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
K. Eto, K. Hashimoto, and H. Nakaya
Preferential inhibition of IKr by MCI-154, a putative cardiotonic Ca2+ sensitizer, in guinea pig atrial cells
Cardiovasc Res, June 1, 1998; 38(3): 685 - 694.
[Abstract] [Full Text] [PDF]



Advertisement